Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
0.2925
+0.0809 (38.23%)
At close: Apr 2, 2025, 4:00 PM
0.2586
-0.0339 (-11.59%)
After-hours: Apr 2, 2025, 7:58 PM EDT

Quoin Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
-8.96-8.69-9.38-21.46-2.1
Upgrade
Depreciation & Amortization
0.10.10.10.10.1
Upgrade
Other Amortization
---0.28-
Upgrade
Asset Writedown & Restructuring Costs
-0.02---
Upgrade
Loss (Gain) From Sale of Investments
-0.25-0.49-0.09--
Upgrade
Stock-Based Compensation
1.261.090.76--
Upgrade
Other Operating Activities
--0.2214.730.38
Upgrade
Change in Accounts Payable
0.280.05-0.221.350.23
Upgrade
Change in Other Net Operating Assets
-0.280.040.12-0.720.05
Upgrade
Operating Cash Flow
-7.86-7.86-8.48-5.72-1.34
Upgrade
Investment in Securities
-1.892.19-9.9--
Upgrade
Other Investing Activities
---0.25-0.63-0.13
Upgrade
Investing Cash Flow
-1.892.19-10.15-0.63-0.13
Upgrade
Short-Term Debt Issued
---3.481.98
Upgrade
Long-Term Debt Issued
---0.14-
Upgrade
Total Debt Issued
---3.611.98
Upgrade
Short-Term Debt Repaid
---0.31--0.05
Upgrade
Long-Term Debt Repaid
-0.6-0.6-0.6-0.3-
Upgrade
Total Debt Repaid
-0.6-0.6-0.91-0.3-0.05
Upgrade
Net Debt Issued (Repaid)
-0.6-0.6-0.913.311.93
Upgrade
Issuance of Common Stock
11.575.8514.8810.1-
Upgrade
Other Financing Activities
--0.030.040.09-0.14
Upgrade
Financing Cash Flow
10.975.2214.0113.51.79
Upgrade
Net Cash Flow
1.22-0.46-4.627.160.32
Upgrade
Cash Interest Paid
---0.39-
Upgrade
Levered Free Cash Flow
-4.28-4.68-6.21-7.63-
Upgrade
Unlevered Free Cash Flow
-4.28-4.68-5.77-7.06-
Upgrade
Change in Net Working Capital
-0.320.020.853.37-
Upgrade
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q